Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells

por Church, Sarah E, Jensen, Shawn M, Antony, Paul A, Restifo, Nicholas P, Fox, Bernard A
Publicado 2014

17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model

por Joshi, Sandeep S., Jiang, Shunlin, Unni, Emmanual, Goding, Stephen R., Fan, Tao, Antony, Paul A., Hornyak, Thomas J.
Publicado 2018

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

por Quezada, Sergio A., Simpson, Tyler R., Peggs, Karl S., Merghoub, Taha, Vider, Jelena, Fan, Xiaozhou, Blasberg, Ronald, Yagita, Hideo, Muranski, Pawel, Antony, Paul A., Restifo, Nicholas P., Allison, James P.
Publicado 2010

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8(+) T cells

por Gattinoni, Luca, Finkelstein, Steven E., Klebanoff, Christopher A., Antony, Paul A., Palmer, Douglas C., Spiess, Paul J., Hwang, Leroy N., Yu, Zhiya, Wrzesinski, Claudia, Heimann, David M., Surh, Charles D., Rosenberg, Steven A., Restifo, Nicholas P.
Publicado 2005

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8(+) T Cells

por Overwijk, Willem W., Theoret, Marc R., Finkelstein, Steven E., Surman, Deborah R., de Jong, Laurina A., Vyth-Dreese, Florry A., Dellemijn, Trees A., Antony, Paul A., Spiess, Paul J., Palmer, Douglas C., Heimann, David M., Klebanoff, Christopher A., Yu, Zhiya, Hwang, Leroy N., Feigenbaum, Lionel, Kruisbeek, Ada M., Rosenberg, Steven A., Restifo, Nicholas P.
Publicado 2003